Observational study / 2014
Lower sodium excretion was linked to a lower risk of cardiovascular events in prehypertensive adults followed post-trial.
During 10 to 15 years of post-trial surveillance of 2,275 prehypertensive TOHP participants not in a sodium reduction intervention, 193 cardiovascular events or cardiovascular disease deaths occurred. Compared with sodium excretion of 3600 to <4800 mg/d, risk for those with <2300 mg/d was 32% lower after multivariable adjustment (HR 0.68; 95% CI, 0.34-1.37; P for trend=0.13). There was a linear 17% increase in risk per 1000 mg/d increase in sodium (P=0.05), with spline curves supporting a linear association continuing down to 1500 mg/d, though data were sparse at the lowest levels.
Shows an association, not proof of cause and effect.
- Study type
- Prospective cohort (extended post-trial surveillance)
- Who was studied
- 2,275 prehypertensive individuals not in a sodium reduction intervention
- What was measured
- Cardiovascular events or cardiovascular disease deaths
THE PAPER
Lower levels of sodium intake and reduced cardiovascular risk.
Cook NR, Appel LJ, Whelton PK. Circulation, 2014.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.